Tag: the war on (some) drugs

Marijuana Social Equity Programs Should Be Redesigned To Directly Support People Harmed By Criminalization 

Ohio voters recently legalized the recreational use of marijuana by adults. In total, 24 states have legalized recreational marijuana use, and Florida, Hawaii, New Hampshire, Pennsylvania and Wisconsin may all soon join these ranks. This metaphorical genie is not going back in the bottle, nor should it because drug prohibition breeds violence and has ruined many lives.

As part of the growing bipartisan recognition that cannabis should be legal and the failed war on drugs has wrongly imprisoned many Americans, social equity programs are increasingly included in marijuana legalization efforts. Social equity programs are intended to deliver restorative justice to persons who were imprisoned or otherwise impacted through the enforcement of drug prohibition policies. Ohio’s marijuana initiative makes it the 17th state to create a statewide social equity program. 

Most states, including California, New York, Arizona and Michigan, and cities, like New York City and Oakland, have implemented social equity programs in two ways. First, they reserve a subset of available cannabis business licenses for individuals who meet the legal definition of a “qualified social equity applicant.” These definitions vary, but no jurisdiction identifies them solely as individuals who were arrested or incarcerated for a marijuana-related offense. 

Instead, individuals typically qualify for licenses that allow them to enter the legal cannabis industry because they lived in a neighborhood that had disproportionately high arrest rates or below-average income. Persons never directly affected by the drug war can frequently access these benefits on equal terms with those affected. Often, large corporate interests have hired or partnered with individuals who meet social equity criteria to act (often unwittingly) as mere figureheads on license applications.

Keep reading

Fifth Michigan City Approves Local Psychedelics Decriminalization Resolution

Another Michigan city has approved a resolution to locally deprioritize enforcement of laws against psychedelic substances, while expressing support for a statewide bill to legalize certain etheogenic plants and fungi.

On Tuesday, the Ypsilanti City Council took testimony from supporters and passed the psychedelics measure in an unanimous 6-0 vote.

The whereas section states that psychedelics can “catalyze profound experiences of personal and spiritual growth, have been shown by scientific and clinical studies and traditional practices to be beneficial to the health and well-being of individuals and communities in addressing” conditions such as anxiety and post-traumatic stress.

It also points out that the Washtenaw County District Attorney’s office expressed support for a similar resolution that was adopted in Ann Arbor in 2020.

The latest measure specifically says that it is not intended to legalize the commercial sale of psychedelics, but it makes the arrest and investigation of people for psychedelics-related activities such as possession and cultivation “the lowest law enforcement priority for the City of Ypsilanti.”

It also declares that “city funds or resources shall not be used in any investigation, detention, arrest, or prosecution arising out of alleged violations of state and federal law regarding the use of Entheogenic Plants.”

Keep reading

Military Veterans Who Received Psychedelic Ibogaine Treatment Saw ‘Dramatic’ And ‘Life-Changing’ Improvements In PTSD And Depression, Stanford Study Finds

Military combat veterans with traumatic brain injuries (TBI) saw “dramatic” and “life-changing” improvements in their symptoms and cognitive functioning immediately after receiving treatment with the psychedelic ibogaine, new research shows.

Stanford University researchers behind the study, which was published in the journal Nature Medicine last week, followed 30 veterans who were functionally disabled from symptoms of TBI such as post-traumatic stress, depression and anxiety and who had a history of repeated blast or combat exposures.

The team, which collaboration with the foundation VETS, Inc., assessed the veterans before and after they visited a clinic in Mexico to receive ibogaine treatment, and they identified profound changes in the participants’ mental health, with minimal side effects.

Prior to the treatment, the veterans each met the criteria for clinically significant levels of disability. Twenty-three had diagnosable PTSD, 14 had anxiety disorder, 15 had alcohol use disorder and 19 had been suicidal at some point in their lifetimes.

After receiving ibogaine, in addition to magnesium to protect against potential heart-related complications, there was an immediate “remarkable reduction” in symptoms, “with large effect sizes” that sustained over time.

Keep reading

GOP Virginia Governor Doesn’t Have ‘Any Interest’ In Legalizing Marijuana Sales Under New Democrat-Led Bills

As Virginia Democrstic lawmakers renew their push to legalize marijuana sales, the Republican governor says the issue isn’t something he’s personally interested in advancing this year.

While advocates are hopeful that commercial legalization could move through both chambers of the legislature, which are now controlled by Democrats, the remarks from Gov. Glenn Youngkin (R) indicate that the plan might not be enacted into law even if it is approved by the House of Delegates and Senate.

Following his State of the Commonwealth address on Wednesday, Youngkin was asked about the prospects of further cannabis reform.

“I just don’t have a lot of interest in pressing forward with marijuana legislation,” he told reporters.

Cannabis is “an area that I really don’t have any interest in,” the governor said.

Keep reading

Why Some Activists Fear Marijuana Rescheduling: Responding To Former FDA Official’s Dismissal Of Our Concerns 

Politico recently published an extensive Q&A with Howard Sklamberg, a former top Food and Drug Administration (FDA) official who currently works at the law firm Arnold and Porter. Many advocates for legalization and restorative justice have concerns about the rescheduling of cannabis to a Schedule III substance—fears that Sklamberg believes are “alarmist and misguided.”

As a longtime advocate, I have to say that I don’t share that view. Honestly, I can’t believe Sklamberg said some of the things that he said—and I think the fears that we have are well-informed, reasoned and practical, if for no other reason than the worrying lack of transparency coming from regulatory agencies since rescheduling was recommended last year. We advocates are not always right, but our track record on drug policy is better than that of the policymakers and regulators who campaigned for, created and continued the so-called war on drugs.

Regulators, elected officials and their surrogates could benefit from hearing and taking seriously the other side: the concerns that advocates have about cannabis rescheduling. I’ve done my best to capture some of them below.

Keep reading

Delaware House Committee Approves Bill To Significantly Expand Medical Marijuana Program Ahead Of Adult-Use Sales Launch

Delaware House lawmakers have approved a bill to significantly expand the state’s medical marijuana program ahead of the launch of adult-use sales that may take another year to implement.

At a meeting of the House Health & Human Development Committee on Wednesday, members took public testimony and then voted to pass the reform legislation from Rep. Ed Osienski (D).

The bill would make a series of changes to Delaware’s medical cannabis program, including removing limitations for patient eligibility based on a specific set of qualifying health conditions. Instead, doctors could issue marijuana recommendations for any condition they see fit.

Osienski, who also sponsored a pair of complementary adult-use legalization and regulation bills that Gov. Jay Carney (D) allowed to become law without his signature last year, said on Wednesday that the medical cannabis legislation will allow the program “to be more successful as the state moves forward with recreational sales, and to make it less expensive and easier for patients to access medical marijuana.”

Keep reading

After Several Failed Efforts, Washington Lawmakers Introduce New Bill To Legalize Home Marijuana Cultivation

Washington State lawmakers are again trying to allow adults in the state to grow their own marijuana, having introduced a new bill that would allow the cultivation of up to six plants at home.

Washington voters legalized marijuana through a ballot measure in 2012, but the law still makes it a felony for anyone but medical patients to grow the plant. And though several bills have been introduced to allow home cultivation over the years—stretching back to 2015—so far each has failed to find traction.

The latest bill, HB 2194, is an update to a homegrow proposal introduced last year, which passed out of one House committee before being pulled from consideration in a second committee. In addition to the six-plant-per-adult limit, it would cap the total number of plants grown by any one household at 15.

Notwithstanding the state’s personal possession limit of one ounce of marijuana flower, adults would also be able to keep the cannabis produced by their legal plants.

“I just see it as a fundamentally illogical thing that we’re doing,” lead sponsor Rep. Shelley Kloba (D) told Marijuana Moment. “We’ve made it criminal to grow a plant whose products you can walk into a retail store and purchase.”

She noted that beer and wine are also both legal, “and those things are legal to produce in your home as a hobbyist. It doesn’t make sense that you can’t do that with cannabis.”

Under Kloba’s plan, it would be a civil infraction for an individual to grow between six and 15 plants, while growing 16 or more plants would be a class C felony—the current penalty for growing any marijuana at home. The felony charge carries a maximum five years imprisonment and up to a $10,000 fine.

Keep reading

Cannabis Holds Potential To Prevent And Reduce Severity Of COVID-19, While Treating Long-Term Symptoms, Study Finds

Cannabis and its compounds hold the potential to limit the “susceptibility and severity of infection” from COVID-19, while also showing promise in the treatment of long COVID symptoms such as anxiety, depression and decreased appetite, according to a new study.

Researchers at Dalhousie University in Canada carried out a comprehensive review of the scientific literature, publishing their findings about marijuana as a preventive therapeutic in the Journal of Clinical Medicine late last month.

The study found that “cannabinoids have been shown to prevent viral entry, mitigate oxidative stress, and alleviate the associated cytokine storm” of early COVID-19 infections.

“Post-SARS-CoV-2 infection, cannabinoids have shown promise in treating symptoms associated with post-acute long COVID-19, including depression, anxiety, post-traumatic stress injury, insomnia, pain, and decreased appetite,” it said.

The research takes into account a long list of existing studies, aiming to fill the knowledge gap on how endocannabinoid system (ECS) modulation might impact patients in the early- and post-infection stages. Prior studies have focused on marijuana as treatment option during the acute phase of a COVID-19 infection.

“Cannabis and cannabinoid-based drugs have shown promise in preventing viral entry, acting as an anti-inflammatory agent, and improving many symptoms associated with post-acute SARS-CoV-2 infections,” the authors concluded.

Keep reading

California Lawmaker Revives Bill To Legalize Marijuana Cafes Months After Governor’s Veto

A California lawmaker is renewing his push to legalize cannabis cafes in the state, with a newly introduced bill and plans to work with the governor and regulators to address concerns that resulted in the last version being vetoed.

Assemblymember Matt Haney (D) is again sponsoring the proposal, which would allow on-site marijuana consumption at licensed businesses, which could also offer non-cannabis food and drinks and host live events such as concerts if they get permission from the local government.

Gov. Gavin Newsom (D) vetoed the prior version, saying that while he appreciated that the intent was to “provide cannabis retailers with increased business opportunities and an avenue to attract new customers,” he felt “concerned this bill could undermine California’s long-standing smoke-free workplace protections.”

“Protecting the health and safety of workers is paramount,” the governor said at the time. “I encourage the author to address this concern in subsequent legislation.”

Accordingly, Haney says he’ll be exploring ways to resolve those concerns in collaboration with the governor’s office and the state Department of Cannabis Control (DCC).

As filed last week, however, it seems the basic provisions of the bill were kept the same as those discussions continue. The sponsor told The San Francisco Standard that the legislation will be amended to address the governor’s concerns “in the coming months.”

Keep reading

West Virginia Senate President Says Marijuana Could Be Legalized To Help Curb Fentanyl Epidemic, ‘Sooner Than Later’

West Virginia’s Republican Senate president says that legalizing marijuana could help ease the state’s crush of fatal fentanyl overdoses, predicting that the policy change will come “sooner than later” but probably not in the new legislative session.

“My gut tells me it might not happen this year,” Senate President Craig Blair (R) said at a media event last week, according to West Virginia Public Broadcasting. “But you’re going to see it sooner than later, because that is a way to combat the issue.”

Data from the Centers for Disease Control and Prevention (CDC) show that West Virginia had more fatal fentanyl overdoses per capital in 2022 than any other state in the nation.

The Senate president also noted that he sees a lot of West Virginia license plates at marijuana dispensaries when he’s visiting other states, according to West Virginia watch.

Speaking to the fentanyl problem, Blair also claimed at the event that “there is a problem in the state of West Virginia when marijuana, over 70 percent of it that gets tested, has fentanyl on it.” He is supporting legislaiton that would apply the death penalty to people who sell fentanyl.

It’s not clear what data, if any, Blair was referencing with that assertion. The organization Partnership to End Addiction says there’s “no solid evidence that marijuana is being laced with fentanyl.”

House Minority Leader Sean Hornbuckle (D) also discussed his own party’s support for legalization in West Virginia.

“We’re a believer in adult-use cannabis,” he said, pointing out that policy change “polls well into the 60s” in terms of percent of voter support.

“That is something that we can have in our toolkit that can help pay for items,” he told the event’s attendees.

Keep reading